Updated:
Confluence Genetics
Confluence Genetics uses genetics and AI to develop sustainable soy solutions. Learn about its strategy, seed varieties, and grain programs at this St.
Confluence Genetics
Confluence Genetics positions itself as a seed innovation company where nature and technology converge. The firm leverages world-leading genetics, artificial intelligence, and a nature-positive ethos to meet rising demand for sustainable soy solutions. The company's strategy centers on developing high-nutrition, energy-dense soy varieties. It deploys capital across genetics research, AI-driven plant science, and independent testing. Confluence Genetics offers proprietary varieties and grain programs, targeting the North American agricultural market. Team size and total deployment are not publicly disclosed. The firm operates from St. Louis, Missouri, with no additional offices listed. No recent operational events have been reported in the last 24 months. The firm's structural differentiator lies in its dual focus on genetics and AI, applied directly to soy. Unlike generic agricultural technology firms, Confluence Genetics owns the full seed development cycle — from genetic innovation to market programs.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
St. Louis
Corporate office
St. Louis, MO, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Confluence Genetics?
No named principals or investment team members are publicly disclosed on the firm's website. Key decision-makers remains unknown.
What investment stages does Confluence Genetics typically target?
The firm focuses on proprietary development of seed varieties and grain programs. It does not disclose specific investment stages such as venture, growth, or buyout.
Is Confluence Genetics structured as a single family office or does it operate more like a venture firm?
Confluence Genetics operates as a seed innovation company with a nature-positive and technology-driven approach. Its funding structure and whether it functions as a family office or venture firm is not disclosed.
Which sectors does Confluence Genetics focus on?
The firm concentrates exclusively on soy innovation, leveraging genetics and AI to produce more nutritious, sustainable, and energy-dense soy solutions. No other sectors are mentioned.
Does Confluence Genetics participate in fund commitments or only direct deals?
The firm does not disclose whether it participates in fund commitments. Public information describes only its direct development and commercialization of proprietary soy varieties.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: